The manufacturer of Reductil is Abbott Laboratories and was founded by Chicago physician Wallace Calvin Abbott in 1888. Abbott Laboratories is a health care and pharmaceuticals company. It has around 60,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, IL, a northern suburb of Chicago, IL, near its manufacturing center in North Chicago, Illinois. In 2001, Abbott acquired Knoll, the pharmaceutical division of BASF.

From the early days of Wallace Abbott producing alkaloid based pills, which he called dosimetric granules, these provided more accurate dosing than methods in use at the time. The subsequent demand soon exceeded the needs of Dr Abbott’s practice and from these modest beginnings, Abbott laboratories was born, to become one of the world’s broad based health care company’s. The company was to become a leader in the discovery development and manufacture of healthcare products.

From the very early days, the company championed scientific investigation to benefit people. Using alkaloid medicine, Abbott’s founders were pioneers in devising new and better ways to deliver medicine granule to care for patients. From these early days of alkaloid based medication, the company took a different direction following the recruitment of a young medical professor, Dr Alfred Burdick. This direction was to shift toward synthetic chemical medicines which were to provide them with tremendous growth. In the following years Abbott entered a period of growth with scientific pursuit and strategic acquisitions.

By 2005 Abbott employed 65,000 people, had sales of 22.5 billion dollars and has products sold in over 130 countries. The company is at the forefront of research and development and is an important contributor to medical research, which includes anesthesia, animal welfare, diabetes care, cardiovascular medication, amongst very many others. The company, in 1985, developed the first licensed test to detect HIV antibodies in blood and the company’s retrovirus and hepatitis test are used to screen more than half the world’s donated blood supply.